A German court invalidated a patent at the center of a CureVac lawsuit against B...
Argenx said Wednesday that its closely watched therapy failed to outperform plac...
After two years of steady decline in biotech, industry optimists might be onto s...
The U.S. must raise federal alcohol taxes to address the alarming rise in alcoho...
MABS-139 is under clinical development by Manhattan Biosolutions and currently i...
FLU-SV-mRNA is under clinical development by Curevac and currently in Phase I fo...
ND-10 ER is under clinical development by Theialife Sciences and currently in Ph...
Meloxicam fast acting is under clinical development by Viatris and currently in ...
NNC-05600004 is under clinical development by Novo Nordisk and currently in Phas...
GUB-014295 is under clinical development by Gubra and currently in Phase I for O...
UI-059 is under clinical development by Korea United Pharm and currently in Phas...
GLB-001 is under clinical development by GluBio Therapeutics and currently in Ph...
GLB-001 is under clinical development by GluBio Therapeutics and currently in Ph...
GLB-001 is under clinical development by GluBio Therapeutics and currently in Ph...
Providers say regulators have overstepped their authority and hobbled critical h...
Join STAT’s Adam Feuerstein and a panel of experts for a Dec. 19 virtual event t...
